We aimed to evaluate the diagnostic and preoperative localization capacity of 99 m Tc methoxyisobutylnitrile (MIBI) parathyroid scintigraphy and ultrasonography (USG) in enlarged parathyroid glands in the primary hyperparathyroidism (pHPT), as well as the relationship between the success rate of these techniques and biochemical values. We retrospectively evaluated 39 patients with clinical and biological evidence of pHPT who referred to the university hospital for MIBI parathyroid scintigraphy. Patients were examined with USG and double-phase MIBI parathyroid scintigraphy for the detection of enlarged parathyroid glands. Preoperative serum intact parathyroid hormone (iPTH) levels, calcium (Ca), phosphate and alkaline phosphatase measurements were obtained. A total of 45 parathyroid lesions in 39 patients were reviewed. Thirty-four patients had a single adenoma and five patients with multi-gland disease had 11 abnormal parathyroid glands including three adenomas, whereas the remaining 8 glands showed hyperplasia. The overall sensitivities of MIBI parathyroid scintigraphy, USG, and combined techniques were 85.3%, 72.5% and 90.4%, respectively; the positive predictive values (PPV) were 89.7%, 85.2%, and 92.6%, respectively. The most successful approach for detection of enlarged parathyroid glands in hyperparathyroidism is the concurrent application of USG and MIBI parathyroid scintigraphy modalities. The concomitance of thyroid diseases decreases the sensitivity of both MIBI parathyroid scintigraphy and USG in enlarged parathyroid glands.
INTRODUCTION
Primary hyperparathyroidism (pHPT) is a disease characterized by idiopathic, pathological hyper functioning of one or more parathyroid glands, leading to excessive parathyroid hormone (PTH) secretion [1] . The main cause of primary hyperparathyroidism is a solitary adenoma, followed by multiple adenomas, hyperplastic glands, and, very rarely, carcinomas [2] . Successful treatment of primary hyperparathyroidism involves identification and excision of enlarged parathyroid glands [3] . Noninvasive imaging techniques, such as ultrasonography (USG), 99 m Tc methoxyisobutylnitrile (MIBI) parathyroid scintigraphy, and magnetic resonance (MR), are commonly used for the identification of enlarged parathyroid glands. All these imaging methods have had varying rates of success along with a lack of the requisite sensitivity to justify the application of any single imaging modality for routine use before surgical neck exploration [4] . Among these techniques, MIBI parathyroid scintigraphy and USG are the main imaging modalities for the preoperative localization of parathyroid adenomas [5] . In this study, we aimed to retrospectively assess the sensitivity of USG, MIBI parathyroid scintigraphy and the combination of both modalities for preoperative localization of enlarged parathyroid glands as well as their relationship with biochemical results for pHPT patients.
MATERIALS AND METHODS

Patients
In this study, we retrospectively evaluated patients with clinical and biological evidence of hyperparathyroidism who referred to the university hospital over a 4- Tc MIBI, planar static images of the anterior view of the neck and upper thorax were obtained with the patient placed in the supine position. Each image was acquired in a 256x256 pixel matrix of 5-min duration. Two images, the initial one at 20 min post-injection (thyroid phase) and the second at 60-120 min (parathyroid phase), were obtained. A gamma camera equipped with a low-energy high-resolution (LEHR) parallel hole collimator was used for image acquisition. SPECT imaging was performed only in patients in whom planar imaging failed to localize the abnormal gland. A positive study was defined when a solitary focus of 99m Tc-MIBI greater than background neck activity was noted on the early or delayed imaging. The site of such uptake was also noted.
Ultrasonography
The ultrasound system used for this study was a General Electric (GE) medical system, a gray scale real-time ultrasound machine, fitted with a 7.5 MHz transducer. The patients were examined in the supine position with hyperextended cervical spine. Ultrasound examinations were performed by two nuclear medicine specialists experienced in neck USG imaging.
The examiner was unaware of any prior imaging results using other techniques, including MIBI parathyroid scintigraphy. An enlarged parathyroid gland was recognized as a homogeneously echogenic structure with less echogenicity than the thyroid gland.
Surgery and Histological Interpretation
The surgical materials were reviewed retrospectively by pathologist without any acquaintance with the semi-quantitative scintigraphic results. Each lesion was classified as either adenoma or hyperplasia. The volume of each gland was calculated by measuring three greatest diameters according to the ellipsoid volume formula.
Laboratory parameters
Levels of serum calcium and phosphate were determined using the spectrophotometric method. Intact parathyroid hormone (iPTH) level was measured with specific chemiluminescence immunoassays. Baseline values of all laboratory parameters had been determined about 1-2 weeks before MIBI parathyroid scintigraphy was done.
Statistics
The collected data were entered into SPSS version 12. Data were expressed as a mean ± SD. Sensitivity was defined as the ratio of true positive tests to the sum of true-positive and false-negative tests. The differences in sensitivity were compared using McNemar' s test for paired data. Quantitative data comparisons were performed with Student' s t-test, Chisquare, and Mann-Whitney U-test. P values of less than 0.05 were considered statistically significant.
RESULTS
Thirty-nine patients (27 women and 12 men; mean age 41 ± 8.3; age range 19-58 years) underwent surgery for parathyroidectomy. Upon surgical exploration, a total of 45 enlarged parathyroid glands were found in 39 patients.; 34 patients had a single adenoma while 5 had a multi-gland disease. Seven of the 39 patients had coexisting thyroid disorders. Thyroid pathology was detected by USG and MIBI parathyroid scintigraphy preoperatively. In the patients with thyroid disorder, 12 enlarged parathyroid glands (9 adenomas and 3 hyperplasias) were detected during surgical exploration. The definitive histological examination revealed that 34 patients had a single adenoma and 5 patients with multi-gland disease had 11 abnormal parathyroid glands including 3 adenomas, whereas the remaining 8 glands showed parathyroid hyperplasia. We found that adenomas were more commonly seen in women, while hyperplasia was more prevalent in men, but these findings were not statistically significant (p >0.05). In all patients, the mean serum levels of calcium, phosphates and iPTH were 11.4±1.5 mg/dl, 2.6±0.9 and 282.9 ± 117.1 pg/ml, respectively. Among 34 patients with a single adenoma, MIBI parathyroid scintigraphy and USG correctly identified the pathology in 90.9% and 87.1% of cases, respectively. Parathyroid adenomas were detected with 96.9% certainty when USG and MIBI parathyroid scintigraphy modalities were applied concurrently (Table 1) . Of a total of 11 parathyroid lesions in 5 multi-gland patients, MIBI parathyroid scintigraphy and USG correctly identified 63.6% (7/11) and 45.4% (5/11) pathologies, respectively. Parathyroid glands were detected with 72.7% (8/11) accuracy when both USG and MIBI parathyroid scintigraphy modalities were applied together. Of the twelve enlarged parathyroid glands in patients with thyroid disorders, MIBI parathyroid scintigraphy and USG correctly detected 41.6% (5/12) and 25% (3/12), respectively. There was a significant difference in the detection sensitivity of parathyroid lesions between patients with and without thyroid pathology for both MIBI parathyroid scintigraphy and USG (p >0.05). One multi-gland patient had two hyperplastic parathyroid glands that were detected neither by MIBI parathyroid scintigraphy nor USG. These glands were localized in the upper pole of both lobes, and one of them weighed less than 0.5 g. In the detection of hyperplastic parathyroid glands, MIBI parathyroid scintigraphy was found to be superior to USG, but the finding is not statistically significant (p >0.05). In our study that included 45 enlarged parathyroid glands in 39 patients, MIBI parathyroid scintigraphy had 85.3% sensitivity, while USG had sensitivity of 72.5%, and their combined use had a sensitivity of 90.4% ( Table 2 ). The localisation of the 37 total parathyroid adenomas were as following: twenty-one (56.8%) were associated with the right lobe (16 in the lower pole, 5 in the upper pole), 16 (43.2%) were associated with the left lobe (13 in the lower pole, 3 in the upper pole). The scintigraphic and ultrasonographic images of the right inferoposterior parathyroid adenoma were shown in Figure 1 .
The correlation analysis of scintigraphy and ultrasonography findings with the laboratory parameters and parathyroid gland size
The range of iPTH levels in adenoma cases was between 129 and 578 pg/ml, while it ranged it 142-298 pg/ml in hyperplasia cases. The range of serum calcium levels for adenoma was between 10.4 and 14.3 mg/dl, and for hyperplasia it was between 10.1 and 12.7 mg/dl. Both iPTH and serum calcium levels showed significant differences between scintigraphy-positive and -negative patients (p=0.01; p=0.013). iPTH levels showed significant differences between USG-positive and -negative patients (p = 0.011), but no significant differences could be found in the serum calcium levels between patients with positive and negative USG examinations (p=0.24). According to the results of the histopathology, the range of the glands' weight for adenomas was between 285 and 4360 mg, while it was between 160 and 1245 mg for hyperplasia cases. The weight of the glands was significantly associated with the detection rate of either MIBI parathyroid scintigraphy or USG in localizing the enlarged parathyroid gland (p=0.001; p=0.021). The comparison of biochemical parameters and gland weight between patients with positive and negative USG/MIBI parathyroid scintigraphy results is shown in Table 3 . There were six parathyroid glands (four of them with hyperplasia, two of them with adenoma) that were detected neither by MIBI parathyroid scintigraphy nor USG. Five of them weighted under 0.5 g.
DISCUSSION
The main pathology in pHPT is insufficient sensitivity of the pathologically altered parathyroid gland to inhibition by ambient calcium [6] . The most frequent reasons for pHPT include parathyroid adenoma and hyperplasia. In our study, enlarged parathyroid glands were found more frequently in women, the finding being in concordance with the existing literature. Surgery is the only curative therapy for pHPT and should be considered for each patient. Imaging techniques of parathyroid glands play the crucial role in preoperative planning of surgical procedures. USG and MIBI parathyroid scintigraphy are the principal imaging techniques and are frequently used together for the preoperative location of pathological parathyroid glands [5, [7] [8] [9] . In our study, MIBI parathyroid scintigraphy and USG had 85.3% and 72.5% sensitivity, respectively. These results show that MIBI parathyroid scintigraphy was superior to USG in localizing enlarged parathyroid glands. The superiority of MIBI parathyroid scintigraphy to USG might be attributed to the additional functional features of scanning technique based on the metabolic activity of the parathyroid gland. Although there are studies similar to our study in the literature, there are also many studies showing the superiority of USG. In our study, the sensitivity of USG was higher than in some previous research [10] [11] [12] , the result probably altered by the fact that examiners in the study were two experienced nuclear medicine specialists having the opportunity to consult each other in the case of equivocal images. Our research showed that the most successful technique for detection of enlarged parathyroid glands is the pragmatic combination of USG and MIBI parathyroid scintigraphy modalities. MIBI parathyroid scintigraphy had 85.3% sensitivity, while USG had 72.5%. On the other hand, the combined application of USG and MIBI parathyroid scintigraphy had 90.4% sensitivity. A preoperative approach that integrates both the anatomic information provided by USG and the physiologic information gathered by MIBI parathyroid scintigraphy has been shown to predict the presence and location of solitary adenomas more accurately than either technique alone. The single-tracer dual-phase technique depends on the washout time of MIBI parathyroid scintigraphy between the thyroid gland and the functionally abnormal parathyroid gland. There is a wide range in reported sensitivity for adenoma (from 58% to 100%) and hyperplasia (from 33% to 78%) in the literature [13] [14] [15] [16] . In our study, the sensitivity of MIBI parathyroid scintigraphy was found to be 90.9% for patients with a single adenoma. It is believed that false-negative MIBI parathyroid scintigraphy is associated with small parathyroid adenomas and multi-glandular disease, and the expression of p-glycoprotein, or multi-drug resistance (MDR)-related protein [17] [18] [19] . It is also related to delayed activity washout from the thyroid gland as in multi-nodular goiters and Hashimoto' s thyroiditis. Enlarged multi-nodular thyroid glands can also limit the sonographic evaluation of parathyroid adenomas [5] .
On the contrary, coexistent benign or malignant thyroid disease has also been associated with false-positive results [19] . In our study, there was a significant difference in detection of parathyroid lesions between patients with and without thyroid pathology for both types of scintigraphy.
The changes in levels of iPTH, calcium, and phosphate, observed in hyperparathyroidism, are an indication of the increased metabolism of pathologic parathyroid gland(s). It has been reported that the gland hypermetabolism found in hyperparathyroidism causes increased tissue perfusion [20] . An increase in the uptake and retention of MIBI is an expected result of the increase in gland perfusion. Increases in both perfusion and functional activity and targeting of abundant mitochondria-rich oxyphil cells seem to be relevant mechanisms of uptake. Some investigators have shown a correlation between serum iPTH levels and MIBI uptake in primary and secondary hyperparathyroidism [11, [21] [22] [23] . Also, it has been reported that MIBI uptake is increased in cases with high serum Ca [24] [25] [26] . Our study confirms that MIBI parathyroid scintigraphy is more likely to be positive in patients with the highest iPTH and calcium levels. In our study, iPTH levels were significantly different in patients with positive and negative USG examinations, while there were no significant differences in serum calcium levels. Another factor that might influence scintigraphic and USG detection of abnormal parathyroid glands seem to be their weight. An abnormal parathyroid gland, as a heavier gland, is more likely to be localized by these techniques than a lighter one. Parathyroid adenomas smaller than 500 mg are not often visualized by using MIBI parathyroid scintigraphy [27] [28] [29] . It has also been reported that the results of USG are affected positively by the weight of abnormal glands in some studies [30, 31] . In our study, the range of glands' weight for adenoma was between 285 and 4360 mg, while it was between 160 and 1245 mg for hyperplasia. We found that the weight of glands was significantly associated with the detection rate of either MIBI parathyroid scintigraphy or USG in localizing enlarged parathyroid glands. (p =0.001; p = 0.024, respectively). 
CONCLUSION
We conclude that the most successful approach for detection of enlarged parathyroid gland in hyperparathyroidism is the concurrent application of USG and MIBI parathyroid scintigraphy modalities in order to detect enlarged parathyroid glands in hyperparathyroidism. The increased preoperative serum iPTH and the glands' weight were correlated with positive MIBI parathyroid scintigraphy and USG study of pathologically altered glands.
